279 related articles for article (PubMed ID: 16750735)
21. Successful use of levosimendan in a patient during cardiopulmonary bypass.
Iriz E; Erer D; Unal Y; Zor H; Ozkose Z; Ozdogan ME
J Card Surg; 2007; 22(2):153-6. PubMed ID: 17338755
[TBL] [Abstract][Full Text] [Related]
22. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
Botha P; Parry G; Dark JH; Macgowan GA
J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
[TBL] [Abstract][Full Text] [Related]
23. Levosimendan for weaning from cardiopulmonary bypass after coronary artery bypass grafting.
Akgul A; Mavioglu L; Katircioglu SF; Pac M; Cobanoglu A
Heart Lung Circ; 2006 Oct; 15(5):320-4. PubMed ID: 16860605
[TBL] [Abstract][Full Text] [Related]
24. Levosimendan Use Increases Cardiac Performance after Coronary Artery Bypass Grafting in End-Stage Renal Disease Patients.
Atalay H; Temizturk Z; Altinsoy HB; Azboy D; Colak S; Atalay A; Dogan OF
Heart Surg Forum; 2016 Oct; 19(5):E230-E236. PubMed ID: 27801303
[TBL] [Abstract][Full Text] [Related]
25. Levosimendan in patients with acute myocardial ischaemia undergoing emergency surgical revascularization.
Lehmann A; Kiessling AH; Isgro F; Zeitler C; Thaler E; Boldt J
Eur J Anaesthesiol; 2008 Mar; 25(3):224-9. PubMed ID: 17892614
[TBL] [Abstract][Full Text] [Related]
26. Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair.
Ponschab M; Hochmair N; Ghazwinian N; Mueller T; Plöchl W
Eur J Anaesthesiol; 2008 Aug; 25(8):627-33. PubMed ID: 18405408
[TBL] [Abstract][Full Text] [Related]
27. Levosimendan in congenital cardiac surgery: a randomized, double-blind clinical trial.
Momeni M; Rubay J; Matta A; Rennotte MT; Veyckemans F; Poncelet AJ; Clement de Clety S; Anslot C; Joomye R; Detaille T
J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):419-24. PubMed ID: 20829069
[TBL] [Abstract][Full Text] [Related]
28. Comparative hemodynamic effects of vasopressin and norepinephrine after milrinone-induced hypotension in off-pump coronary artery bypass surgical patients.
Jeon Y; Ryu JH; Lim YJ; Kim CS; Bahk JH; Yoon SZ; Choi JY
Eur J Cardiothorac Surg; 2006 Jun; 29(6):952-6. PubMed ID: 16675238
[TBL] [Abstract][Full Text] [Related]
29. Slow induction of milrinone after coronary artery bypass grafting.
Shibata T; Suehiro S; Sasaki Y; Hosono M; Nishi S; Kinoshita H
Ann Thorac Cardiovasc Surg; 2001 Feb; 7(1):23-7. PubMed ID: 11343562
[TBL] [Abstract][Full Text] [Related]
30. Haemodynamic and biological effects of intravenous milrinone in patients with a low cardiac output syndrome following cardiac surgery: multicentre study.
George M; Lehot JJ; Estanove S
Eur J Anaesthesiol Suppl; 1992; 5():31-4. PubMed ID: 1600967
[TBL] [Abstract][Full Text] [Related]
31. [Hemodynamic effects of levosimendan following cardiac surgery].
Alvarez J; Taboada M; Rodríguez J; Caruezo V; Bouzada M; Campaña O; Bascuas B; Pérez-Paz J; Ginesta V
Rev Esp Anestesiol Reanim; 2005; 52(7):389-94. PubMed ID: 16200918
[TBL] [Abstract][Full Text] [Related]
32. Perioperative nesiritide versus milrinone in high-risk coronary artery bypass graft patients.
Brackbill ML; Stam MD; Schuller-Williams RV; Dhavle AA
Ann Pharmacother; 2007 Mar; 41(3):427-32. PubMed ID: 17311834
[TBL] [Abstract][Full Text] [Related]
33. Effect of low-dose milrinone on gastric intramucosal pH and systemic inflammation after hypothermic cardiopulmonary bypass.
Yamaura K; Okamoto H; Akiyoshi K; Irita K; Taniyama T; Takahashi S
J Cardiothorac Vasc Anesth; 2001 Apr; 15(2):197-203. PubMed ID: 11312479
[TBL] [Abstract][Full Text] [Related]
34. Hemodynamic effects of levosimendan in acute myocardial infarction complicated by cardiogenic shock and high systemic vascular resistance.
Tsagalou EP; Kanakakis J; Anastasiou-Nana MI; Drakos SG; Ntalianis AS; Malliaras K; Lazaris N; Katsaros F; Nanas JN
Acute Card Care; 2009; 11(2):99-106. PubMed ID: 19353405
[TBL] [Abstract][Full Text] [Related]
35. Effects of intravenous levosimendan on human coronary vasomotor regulation, left ventricular wall stress, and myocardial oxygen uptake.
Michaels AD; McKeown B; Kostal M; Vakharia KT; Jordan MV; Gerber IL; Foster E; Chatterjee K
Circulation; 2005 Mar; 111(12):1504-9. PubMed ID: 15781741
[TBL] [Abstract][Full Text] [Related]
36. Evoked changes in cardiovascular function in rats by infusion of levosimendan, OR-1896 [(R)-N-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)acetamide], OR-1855 [(R)-6-(4-aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one], dobutamine, and milrinone: comparative effects on peripheral resistance, cardiac output, dP/dt, pulse rate, and blood pressure.
Segreti JA; Marsh KC; Polakowski JS; Fryer RM
J Pharmacol Exp Ther; 2008 Apr; 325(1):331-40. PubMed ID: 18171907
[TBL] [Abstract][Full Text] [Related]
37. Effects of high-dose glucose-insulin-potassium on myocardial metabolism after coronary surgery in patients with Type II diabetes.
Szabó Z; Arnqvist H; Håkanson E; Jorfeldt L; Svedjeholm R
Clin Sci (Lond); 2001 Jul; 101(1):37-43. PubMed ID: 11410112
[TBL] [Abstract][Full Text] [Related]
38. Levosimendan versus intra-aortic balloon pump in high-risk cardiac surgery patients.
Severi L; Lappa A; Landoni G; Di Pirro L; Luzzi SJ; Caravetta P; Cipullo P; Menichetti A
J Cardiothorac Vasc Anesth; 2011 Aug; 25(4):632-6. PubMed ID: 21546269
[TBL] [Abstract][Full Text] [Related]
39. An 11-year, single-institution analysis of intra-aortic balloon pump use in cardiac surgery.
Zaky SS; Hanna AH; Sakr Esa WA; Xu M; Lober C; Sessler DI; Gonzalez-Stawinski G; Savage RM; Bashour CA
J Cardiothorac Vasc Anesth; 2009 Aug; 23(4):479-83. PubMed ID: 19285430
[TBL] [Abstract][Full Text] [Related]
40. Influence of levosimendan on organ dysfunction in patients with severely reduced left ventricular function undergoing cardiac surgery.
Erb J; Beutlhauser T; Feldheiser A; Schuster B; Treskatsch S; Grubitzsch H; Spies C
J Int Med Res; 2014 Jun; 42(3):750-64. PubMed ID: 24781725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
